GMED SEC filings (2026)
CIK 1237831 · Surgical & Medical Instruments & Apparatus (SIC 3841) · incorporated in DE · fiscal year ends in December
772 filings on EDGAR since 2003 · 17 annual, 44 quarterly, 130 current · financial statements · earnings
What happened, last 12 months#
Every earnings release with its print, every report with its quarter, the other 8-Ks by what they covered, the proxy statements, and each day an insider bought or sold — newest first, each line opening the filing on EDGAR. The index by form and year follows.
September 2026
- Sep 15Insider saleTOBIN JAMES R (Director) sold 30,000 Class A shares for $2.2M at $74.58
August 2026
June 2026
May 2026
April 2026
- Apr 24ProxyProxy · Additional proxy materials
- Apr 24ProxyProxy · Proxy statement
March 2026
February 2026
- Feb 25Insider saleHuller Kelly (EVP, GC, Corporate Secretary) sold 20,000 Class A shares for $1.9M at $94.50 under a 10b5-1 plan
- Feb 24EarningsEarnings release — EPS $1.28 vs $1.06 est. (+20.8%); revenue $826.4M (+26% y/y) 4.7%
- Feb 24ReportAnnual report, FY2025 — revenue $2.94B (+17% y/y), net income $537.9M, EPS $3.92
- Feb 12Insider saleHuller Kelly (EVP, GC, Corporate Secretary) sold 10,000 Class A shares for $877K at $87.67 under a 10b5-1 plan
January 2026
November 2025
Insider transactions#
What officers, directors and 10% holders reported on Forms 4 and 5 over the last 13 months, from the documents themselves: one insider’s trades of one kind on one day are one row, with the shares, the price range and the total as filed. Open-market buys and sells first; awards, exercises, tax withholding, gifts and employee-plan purchases are grouped below them.
Over the last 13 months insiders sold $9.8M in 7 sales and bought nothing on the open market; 30 other transactions (awards, exercises, tax withholding, gifts and plan purchases).
| Date | Insider |
|---|---|
| Sep 15, 2026Form 4 | TOBIN JAMES RDirectorSold · Class A · $2.2M · 30,000 sh |
| Aug 18, 2026Form 4 | ZARRILLI STEPHEN TDirectorSold · Class A · $2.2M · 25,000 sh |
| Jun 5, 2026Form 4 | Davidar David DDirectorSold · Class A · $2.0M · 25,000 sh |
| Feb 25, 2026Form 4 | Huller KellyEVP, GC, Corporate SecretarySold · Class A · $1.9M · 20,000 sh · 10b5-1 |
| Feb 12, 2026Form 4 | Huller KellyEVP, GC, Corporate SecretarySold · Class A · $877K · 10,000 sh · 10b5-1 |
| Jan 8, 2026Form 4 | Kline KyleSenior Vice President, CFOSold · Class A · $363K · 3,594 sh · 10b5-1 |
| Jan 8, 2026Form 4 | Norwalk Leslie VDirectorSold · Class A · $202K · 2,000 sh · 10b5-1 |
Awards, exercises, withholding and plan purchases · 30 transactions
| Date | Insider |
|---|---|
| Sep 15, 2026Form 4 | TOBIN JAMES RDirectorExercise or conversion · Class A · $1.8M · 30,000 sh |
| Sep 15, 2026Form 4 | TOBIN JAMES RDirectorExercise or conversion · Class A · $0 · 30,000 sh |
| Aug 18, 2026Form 4 | ZARRILLI STEPHEN TDirectorExercise or conversion · Class A · $1.3M · 25,000 sh |
| Aug 18, 2026Form 4 | ZARRILLI STEPHEN TDirectorExercise or conversion · Class A · $0 · 25,000 sh |
| Jul 27, 2026Form 4 | Davidar David DDirectorGift · Class A · $0 · 2,500 sh |
| Jun 5, 2026Form 4 | Davidar David DDirectorExercise or conversion · Class A · $657K · 25,000 sh |
| Jun 5, 2026Form 4 | Davidar David DDirectorExercise or conversion · Class A · $0 · 25,000 sh |
| Jun 4, 2026Form 4 | RHOADS ANN DDirectorExercise or conversion · Class A · $657K · 25,000 sh |
| Jun 4, 2026Form 4 | RHOADS ANN DDirectorExercise or conversion · Class A · $0 · 25,000 sh |
| Feb 25, 2026Form 4 | Huller KellyEVP, GC, Corporate SecretaryExercise or conversion · Class A · $872K · 20,000 sh · 10b5-1 |
| Feb 25, 2026Form 4 | Huller KellyEVP, GC, Corporate SecretaryExercise or conversion · Class A · $0 · 20,000 sh · 10b5-1 |
| Feb 12, 2026Form 4 | Huller KellyEVP, GC, Corporate SecretaryExercise or conversion · Class A · $456K · 10,000 sh · 10b5-1 |
| Feb 12, 2026Form 4 | Huller KellyEVP, GC, Corporate SecretaryExercise or conversion · Class A · $0 · 10,000 sh · 10b5-1 |
| Jan 21, 2026Form 4 | Paul David CExecutive Chairman · Director · 10% ownerAward · Class A · $0 · 100,000 sh |
| Jan 21, 2026Form 4 | Pfeil Keith WPresident, CEO · DirectorAward · Class A · $0 · 100,000 sh |
| Jan 21, 2026Form 4 | Huller KellyEVP, GC, Corporate SecretaryAward · Class A · $0 · 40,000 sh |
| Jan 21, 2026Form 4 | Kline KyleSenior Vice President, CFOAward · Class A · $0 · 30,000 sh |
| Jan 21, 2026Form 4 | Davidar David DDirectorAward · Class A · $0 · 15,000 sh |
| Jan 21, 2026Form 4 | Wolterman DanDirectorAward · Class A · $0 · 15,000 sh |
| Jan 21, 2026Form 4 | DeFord John ADirectorAward · Class A · $0 · 15,000 sh |
| Jan 21, 2026Form 4 | ZARRILLI STEPHEN TDirectorAward · Class A · $0 · 15,000 sh |
| Jan 21, 2026Form 4 | TOBIN JAMES RDirectorAward · Class A · $0 · 15,000 sh |
| Jan 21, 2026Form 4 | RHOADS ANN DDirectorAward · Class A · $0 · 15,000 sh |
| Jan 21, 2026Form 4 | Lemaitre DanDirectorAward · Class A · $0 · 15,000 sh |
| Jan 21, 2026Form 4 | Douglas Robert AndrewDirectorAward · Class A · $0 · 15,000 sh |
| Jan 21, 2026Form 4 | Norwalk Leslie VDirectorAward · Class A · $0 · 15,000 sh |
| Jan 8, 2026Form 4 | Kline KyleSenior Vice President, CFOExercise or conversion · Class A · $186K · 3,594 sh · 10b5-1 |
| Jan 8, 2026Form 4 | Kline KyleSenior Vice President, CFOExercise or conversion · Class A · $0 · 3,594 sh · 10b5-1 |
| Dec 1, 2025Form 4 | Kline KyleSenior Vice President, CFOExercise or conversion · Class A · $0 · 4,896 sh |
| Jan 2, 2025Form 4 | Davidar David DDirectorGift · Class A · $0 · 6,100 sh |
Reports and proxy statements#
Annual reports (10-K, 20-F, 40-F), quarterly reports (10-Q), current reports (8-K, 6-K) and proxy statements, newest first. An 8-K is described by its items. A form opens the document on EDGAR, or the filing’s index where it furnishes exhibits (an earnings release is the 8-K’s Exhibit 99.1).
2026 · 11 filings
| Filed | What it is |
|---|---|
| Aug 6, 202610-Q | Quarterly report, Q2 2026 — revenue $789.6M (+6% y/y), net income $151.6M, EPS $1.10 |
| Aug 6, 20268-K | Earnings release — EPS $1.34 vs $1.12 est. (+19.6%); revenue $789.6M (+6% y/y) 1.6% |
| Jun 4, 20268-K | Directors or officers; compensation; Shareholder vote results |
| May 7, 202610-Q | Quarterly report, Q1 2026 — revenue $759.9M (+27% y/y), net income $124.3M, EPS $0.90 |
| May 7, 20268-K | Earnings release — EPS $1.12 vs $0.92 est. (+21.7%); revenue $759.9M (+27% y/y) 8.4% |
| Apr 24, 2026DEFA14A | Additional proxy materials |
| Apr 24, 2026DEF 14A | Proxy statement |
| Mar 23, 20268-K | Directors or officers; compensation; Regulation FD disclosure |
| Feb 24, 202610-K | Annual report, FY2025 — revenue $2.94B (+17% y/y), net income $537.9M, EPS $3.92 |
| Feb 24, 20268-K | Earnings release — EPS $1.28 vs $1.06 est. (+20.8%); revenue $826.4M (+26% y/y) 4.7% |
| Jan 7, 20268-K | Results of operations |
2025 · 16 filings
| Filed | What it is |
|---|---|
| Nov 6, 202510-Q | Quarterly report, Q3 2025 — revenue $769.0M (+23% y/y), net income $119.0M, EPS $0.88 |
| Nov 6, 20258-K | Earnings release — EPS $1.18 vs $0.79 est. (+49.4%); revenue $769.0M (+23% y/y) 35.9% |
| Aug 7, 202510-Q | Quarterly report, Q2 2025 — revenue $745.3M (+18% y/y), net income $202.8M, EPS $1.49 |
| Aug 7, 20258-K | Results of operations |
| Jul 21, 20258-K | Results of operations; Directors or officers; compensation; Regulation FD disclosure |
| Jun 5, 20258-K | Directors or officers; compensation; Shareholder vote results |
| May 15, 20258-K | Other events |
| May 8, 202510-Q | Quarterly report, Q1 2025 — revenue $598.1M (−1% y/y), net income $75.5M, EPS $0.54 |
| May 8, 20258-K | Results of operations |
| Apr 25, 2025DEFA14A | Additional proxy materials |
| Apr 25, 2025DEF 14A | Proxy statement |
| Apr 3, 20258-K | Completion of an acquisition or disposition; Regulation FD disclosure |
| Feb 20, 202510-K | Annual report, FY2024 — revenue $2.52B (+61% y/y), net income $103.0M, EPS $0.75 |
| Feb 20, 20258-K | Results of operations |
| Feb 6, 20258-K | Material definitive agreement; Regulation FD disclosure; Other events |
| Jan 8, 20258-K | Results of operations |
2024 · 14 filings
| Filed | What it is |
|---|---|
| Nov 5, 202410-Q | Quarterly report, Q3 2024 — revenue $625.7M (+63% y/y), net income $51.8M, EPS $0.38 |
| Nov 5, 20248-K | Results of operations |
| Aug 13, 20248-K | Other events |
| Aug 6, 202410-Q | Quarterly report, Q2 2024 — revenue $629.7M (+116% y/y), net income $31.8M, EPS $0.23 |
| Aug 6, 20248-K | Results of operations |
| Jun 6, 20248-K | Directors or officers; compensation; Shareholder vote results |
| May 7, 202410-Q | Quarterly report, Q1 2024 — revenue $606.7M (+119% y/y), net income −$7.1M, EPS −$0.05 |
| May 7, 20248-K | Results of operations |
| Apr 26, 2024DEFA14A | Additional proxy materials |
| Apr 26, 2024DEF 14A | Proxy statement |
| Feb 21, 202410-K | Annual report, FY2023 — revenue $1.57B (+53% y/y), net income $122.9M, EPS $1.07 |
| Feb 20, 20248-K | Results of operations |
| Feb 5, 20248-K | Directors or officers; compensation |
| Jan 10, 20248-K | Results of operations |
2023 · 22 filings — 13 × 8-K, 3 × 10-Q, 2 × DEFA14A and 4 other forms
| Filed | What it is |
|---|---|
| Nov 7, 202310-Q | Quarterly report, Q3 2023 — revenue $383.6M (+51% y/y), net income $998K, EPS $0.01 |
| Aug 3, 202310-Q | Quarterly report, Q2 2023 — revenue $291.6M (+11% y/y), net income $57.7M, EPS $0.57 |
| May 4, 202310-Q | Quarterly report, Q1 2023 — revenue $276.7M (+20% y/y), net income $49.1M, EPS $0.48 |
| May 2, 2023DEFA14A | Additional proxy materials |
| Apr 28, 2023DEFA14A | Additional proxy materials |
| Apr 28, 2023DEF 14A | Proxy statement |
| Mar 16, 202310-K/A | Annual report, amended |
| Feb 21, 202310-K | Annual report, FY2022 — revenue $1.02B (+7% y/y), net income $190.2M, EPS $1.85 |
14 current reports (8-K) not listed; the year is on EDGAR.
2022 · 13 filings — 7 × 8-K, 3 × 10-Q, 1 × 10-K and 2 other forms
| Filed | What it is |
|---|---|
| Nov 8, 202210-Q | Quarterly report, Q3 2022 — revenue $254.1M (+11% y/y), net income $47.4M, EPS $0.47 |
| Aug 4, 202210-Q | Quarterly report, Q2 2022 — revenue $263.6M (+5% y/y), net income $54.6M, EPS $0.53 |
| May 10, 202210-Q | Quarterly report, Q1 2022 — revenue $230.5M (+1% y/y), net income $38.1M, EPS $0.37 |
| Apr 21, 2022DEFA14A | Additional proxy materials |
| Apr 21, 2022DEF 14A | Proxy statement |
| Feb 17, 202210-K | Annual report, FY2021 — revenue $958.1M (+21% y/y), net income $149.2M, EPS $1.44 |
7 current reports (8-K) not listed; the year is on EDGAR.
2021 · 11 filings — 5 × 8-K, 3 × 10-Q, 1 × 10-K and 2 other forms
| Filed | What it is |
|---|---|
| Nov 4, 202110-Q | Quarterly report, Q3 2021 — revenue $229.7M (+21% y/y), net income $47.2M, EPS $0.45 |
| Aug 4, 202110-Q | Quarterly report, Q2 2021 — revenue $251.0M (+69% y/y), net income $41.5M, EPS $0.40 |
| May 4, 202110-Q | Quarterly report, Q1 2021 — revenue $227.3M, net income $45.3M, EPS $0.44 |
| Apr 22, 2021DEFA14A | Additional proxy materials |
| Apr 22, 2021DEF 14A | Proxy statement |
| Feb 17, 202110-K | Annual report, FY2020 — revenue $789.0M (+0% y/y), net income $102.3M, EPS $1.01 |
5 current reports (8-K) not listed; the year is on EDGAR.
2020 · 15 filings — 8 × 8-K, 3 × 10-Q, 1 × 10-K and 3 other forms
| Filed | What it is |
|---|---|
| Oct 28, 202010-Q | Quarterly report |
| Aug 5, 202010-Q | Quarterly report, Q2 2020 — revenue $148.9M (−23% y/y), net income −$20.8M |
| May 7, 202010-Q | Quarterly report, Q3 2020 — revenue $190.6M (−3% y/y), net income $25.9M |
| Apr 23, 2020DEFA14A | Additional proxy materials |
| Apr 23, 2020DEF 14A | Proxy statement |
| Mar 2, 202010-K/A | Annual report, amended |
| Feb 20, 202010-K | Annual report |
8 current reports (8-K) not listed; the year is on EDGAR.
2019 · 15 filings — 9 × 8-K, 3 × 10-Q, 1 × 10-K and 2 other forms
| Filed | What it is |
|---|---|
| Nov 6, 201910-Q | Quarterly report, Q3 2019 — revenue $196.2M (+16% y/y), net income $38.3M, EPS $0.38 |
| Aug 1, 201910-Q | Quarterly report, Q2 2019 — revenue $194.5M (+12% y/y), net income $38.2M, EPS $0.38 |
| May 2, 201910-Q | Quarterly report, Q1 2019 — revenue $182.9M (+5% y/y), net income $33.2M, EPS $0.33 |
| Apr 25, 2019DEFA14A | Additional proxy materials |
| Apr 25, 2019DEF 14A | Proxy statement |
| Feb 21, 201910-K | Annual report, FY2018 — revenue $713.0M (+12% y/y), net income $156.5M, EPS $1.54 |
9 current reports (8-K) not listed; the year is on EDGAR.
2018 · 14 filings — 8 × 8-K, 3 × 10-Q, 1 × 10-K and 2 other forms
| Filed | What it is |
|---|---|
| Nov 8, 201810-Q | Quarterly report, Q3 2018 — revenue $169.2M (+12% y/y), net income $35.2M, EPS $0.35 |
| Aug 2, 201810-Q | Quarterly report, Q2 2018 — revenue $173.4M (+14% y/y), net income $45.0M, EPS $0.44 |
| May 3, 201810-Q | Quarterly report, Q1 2018 — revenue $174.4M (+12% y/y), net income $39.5M, EPS $0.39 |
| Apr 26, 2018DEFA14A | Additional proxy materials |
| Apr 26, 2018DEF 14A | Proxy statement |
| Feb 22, 201810-K | Annual report, FY2017 — revenue $636.0M (+13% y/y), net income $107.3M, EPS $1.10 |
8 current reports (8-K) not listed; the year is on EDGAR.
2017 · 17 filings — 11 × 8-K, 3 × 10-Q, 1 × 10-K and 2 other forms
| Filed | What it is |
|---|---|
| Nov 9, 201710-Q | Quarterly report, Q3 2017 — revenue $151.7M (+12% y/y), net income $25.6M, EPS $0.26 |
| Aug 3, 201710-Q | Quarterly report, Q2 2017 — revenue $152.4M (+11% y/y), net income $28.7M, EPS $0.29 |
| May 4, 201710-Q | Quarterly report, Q1 2017 — revenue $155.8M (+12% y/y), net income $28.7M, EPS $0.30 |
| Apr 27, 2017DEFA14A | Additional proxy materials |
| Apr 27, 2017DEF 14A | Proxy statement |
| Mar 16, 201710-K | Annual report, FY2016 — revenue $564.0M (+4% y/y), net income $104.3M, EPS $1.08 |
11 current reports (8-K) not listed; the year is on EDGAR.
2016 · 15 filings — 9 × 8-K, 3 × 10-Q, 1 × 10-K and 2 other forms
Counted, not listed; the year is on EDGAR.
2015 · 21 filings — 15 × 8-K, 3 × 10-Q, 1 × 10-K and 2 other forms
Counted, not listed; the year is on EDGAR.
2014 · 14 filings — 8 × 8-K, 3 × 10-Q, 1 × 10-K and 2 other forms
Counted, not listed; the year is on EDGAR.
2013 · 17 filings — 9 × 8-K, 3 × 10-Q, 1 × 10-K and 4 other forms
Counted, not listed; the year is on EDGAR.
2012 · 6 filings — 3 × 8-K, 2 × 10-Q, 1 × 10-Q/A
Counted, not listed; the year is on EDGAR.
Insider, ownership and other filings#
Insider ownership (Forms 3, 4, 5 and 144), beneficial ownership (Schedules 13D and 13G), registration and prospectus (S-1, S-3, S-8, 424B and related) and the rest, counted by year, with the newest 25 of each of the latest 3 years shown. A Form 4 is one insider’s transaction report; a 13G is a passive holder above five percent.
2026 · 35 filings — 23 × 4, 8 × 144, 1 × 4/A and 3 other forms
| Filed | What it is |
|---|---|
| Sep 16, 20264 | Insider transaction (Form 4) |
| Sep 15, 2026144 | Notice of proposed sale (Form 144) |
| Aug 19, 20264 | Insider transaction (Form 4) |
| Aug 18, 2026144 | Notice of proposed sale (Form 144) |
| Jul 28, 20264 | Insider transaction (Form 4) |
| Jun 9, 20264 | Insider transaction (Form 4) |
| Jun 8, 20264 | Insider transaction (Form 4) |
| Jun 5, 2026144 | Notice of proposed sale (Form 144) |
| May 27, 2026SD | Specialized disclosure (conflict minerals) |
| Apr 30, 2026SCHEDULE 13G | Other filings |
| Apr 14, 2026144 | Notice of proposed sale (Form 144) |
| Mar 26, 2026SCHEDULE 13G/A | Other filings |
| Feb 27, 20264 | Insider transaction (Form 4) |
| Feb 25, 2026144 | Notice of proposed sale (Form 144) |
| Feb 17, 20264 | Insider transaction (Form 4) |
| Feb 12, 2026144 | Notice of proposed sale (Form 144) |
| Jan 23, 20264 | Insider transaction (Form 4) |
| Jan 23, 20264 | Insider transaction (Form 4) |
| Jan 23, 20264 | Insider transaction (Form 4) |
| Jan 23, 20264 | Insider transaction (Form 4) |
| Jan 23, 20264 | Insider transaction (Form 4) |
| Jan 23, 20264 | Insider transaction (Form 4) |
| Jan 23, 20264 | Insider transaction (Form 4) |
| Jan 23, 20264 | Insider transaction (Form 4) |
| Jan 23, 20264 | Insider transaction (Form 4) |
The newest 25 of 35 shown; the full year is on EDGAR.
2025 · 41 filings — 25 × 4, 10 × 144, 4 × SCHEDULE 13G/A and 2 other forms
| Filed | What it is |
|---|---|
| Dec 16, 20254 | Insider transaction (Form 4) |
| Dec 12, 2025144 | Notice of proposed sale (Form 144) |
| Dec 10, 20254 | Insider transaction (Form 4) |
| Dec 3, 20254 | Insider transaction (Form 4) |
| Dec 1, 2025144 | Notice of proposed sale (Form 144) |
| Nov 28, 20254 | Insider transaction (Form 4) |
| Nov 25, 2025144 | Notice of proposed sale (Form 144) |
| Nov 13, 20254 | Insider transaction (Form 4) |
| Nov 13, 20254 | Insider transaction (Form 4) |
| Nov 12, 2025144 | Notice of proposed sale (Form 144) |
| Nov 12, 2025144 | Notice of proposed sale (Form 144) |
| Nov 10, 2025144 | Notice of proposed sale (Form 144) |
| Nov 10, 20254 | Insider transaction (Form 4) |
| Nov 7, 2025144 | Notice of proposed sale (Form 144) |
| Sep 16, 20254 | Insider transaction (Form 4) |
| Sep 15, 2025144 | Notice of proposed sale (Form 144) |
| Aug 27, 20254 | Insider transaction (Form 4) |
| Aug 27, 20254 | Insider transaction (Form 4) |
| Aug 27, 20253 | Initial insider holdings (Form 3) |
| May 29, 2025SD | Specialized disclosure (conflict minerals) |
| May 14, 2025SCHEDULE 13G/A | Other filings |
| Apr 24, 2025SCHEDULE 13G/A | Other filings |
| Mar 28, 20254 | Insider transaction (Form 4) |
| Mar 28, 20254 | Insider transaction (Form 4) |
| Mar 28, 20254 | Insider transaction (Form 4) |
The newest 25 of 41 shown; the full year is on EDGAR.
2024 · 61 filings — 30 × 4, 21 × 144, 6 × SC 13G/A and 3 other forms
| Filed | What it is |
|---|---|
| Dec 4, 20244 | Insider transaction (Form 4) |
| Dec 2, 2024144 | Notice of proposed sale (Form 144) |
| Nov 25, 20244 | Insider transaction (Form 4) |
| Nov 25, 20244 | Insider transaction (Form 4) |
| Nov 25, 20244 | Insider transaction (Form 4) |
| Nov 21, 2024144 | Notice of proposed sale (Form 144) |
| Nov 21, 2024144 | Notice of proposed sale (Form 144) |
| Nov 21, 2024144 | Notice of proposed sale (Form 144) |
| Nov 21, 2024144 | Notice of proposed sale (Form 144) |
| Nov 21, 2024144 | Notice of proposed sale (Form 144) |
| Nov 20, 20244 | Insider transaction (Form 4) |
| Nov 14, 2024SC 13G/A | Passive holder above 5% (Schedule 13G), amended |
| Nov 8, 20244 | Insider transaction (Form 4) |
| Nov 8, 20244 | Insider transaction (Form 4) |
| Nov 6, 2024144 | Notice of proposed sale (Form 144) |
| Nov 6, 2024144 | Notice of proposed sale (Form 144) |
| Oct 18, 20244 | Insider transaction (Form 4) |
| Oct 18, 20244 | Insider transaction (Form 4) |
| Oct 16, 2024144 | Notice of proposed sale (Form 144) |
| Oct 16, 2024144 | Notice of proposed sale (Form 144) |
| Oct 16, 2024144 | Notice of proposed sale (Form 144) |
| Oct 16, 2024144 | Notice of proposed sale (Form 144) |
| Oct 4, 2024UPLOAD | Letter from the SEC staff |
| Oct 2, 2024CORRESP | Letter to the SEC |
| Sep 19, 2024UPLOAD | Letter from the SEC staff |
The newest 25 of 61 shown; the full year is on EDGAR.
2023 · 52 filings — 24 × 4, 7 × 425, 6 × SC 13G/A and 12 other forms
Counted, not listed; the year is on EDGAR.
2022 · 24 filings — 18 × 4, 5 × SC 13G/A, 1 × SD
Counted, not listed; the year is on EDGAR.
2021 · 29 filings — 22 × 4, 4 × SC 13G/A, 1 × S-8 and 2 other forms
Counted, not listed; the year is on EDGAR.
2020 · 31 filings — 22 × 4, 6 × SC 13G/A, 1 × 4/A and 2 other forms
Counted, not listed; the year is on EDGAR.
2019 · 33 filings — 24 × 4, 4 × 3, 4 × SC 13G/A and 1 other form
Counted, not listed; the year is on EDGAR.
2018 · 32 filings — 26 × 4, 4 × SC 13G/A, 1 × 3 and 1 other form
Counted, not listed; the year is on EDGAR.
2017 · 26 filings — 19 × 4, 5 × SC 13G/A, 1 × NT 10-K and 1 other form
Counted, not listed; the year is on EDGAR.
2016 · 23 filings — 15 × 4, 4 × SC 13G/A, 2 × UPLOAD and 2 other forms
Counted, not listed; the year is on EDGAR.
2015 · 27 filings — 16 × 4, 4 × SC 13G/A, 3 × 3 and 4 other forms
Counted, not listed; the year is on EDGAR.
2014 · 26 filings — 18 × 4, 3 × SC 13G/A, 2 × SC 13G and 3 other forms
Counted, not listed; the year is on EDGAR.
2013 · 46 filings — 34 × 4, 4 × SC 13G, 2 × 5 and 4 other forms
Counted, not listed; the year is on EDGAR.
2012 · 53 filings — 18 × 4, 12 × 3, 8 × CORRESP and 9 other forms
Counted, not listed; the year is on EDGAR.
2007 · 2 filings — 1 × REGDEX, 1 × REGDEX/A
Counted, not listed; the year is on EDGAR.
2006 · 1 filing — 1 × REGDEX
Counted, not listed; the year is on EDGAR.
2005 · 2 filings — 2 × REGDEX/A
Counted, not listed; the year is on EDGAR.
2004 · 4 filings — 2 × REGDEX, 2 × REGDEX/A
Counted, not listed; the year is on EDGAR.
2003 · 3 filings — 2 × REGDEX/A, 1 × REGDEX
Counted, not listed; the year is on EDGAR.
About this data
Globus Medical Inc. (GMED) has 772 filings on EDGAR going back to 2003: 17 annual reports, 44 quarterly reports and 130 current reports, plus proxy statements, insider forms and ownership schedules. Its latest annual report, a 10-K, was filed on Feb 24, 2026 for the fiscal year ended Dec 31, 2025. The most recent 8-K, on Aug 6, 2026, covered results of operations. Over the last 13 months insiders sold $9.8M in 7 sales and bought nothing on the open market; 30 other transactions (awards, exercises, tax withholding, gifts and plan purchases). Not investment advice.
Every row is a filing EDGAR lists for the registrants that have been Globus Medical Inc., read from the SEC’s submissions index each morning; a filing accepted after that read appears the next day. Where a company changed its filing entity (a holding-company reorganisation, Google into Alphabet) the predecessor’s filings are shown for the years it filed as the company, derived from the filings themselves. Dates are the filing date; the period is the report’s own. The latest 3 years of reports are listed in full, the next years to 10 without their 8-Ks, and older years are counted; the other forms are counted too, with the newest 25 of each of the latest 3 years shown. Insider transactions are the Form 4 and Form 5 documents themselves, filed since January 2026, every number as the insider filed it: a day’s lots are summed, a blank price adds its shares and no dollars, and a purchase through an employee stock plan is a plan purchase, not insider buying. The documents stay on sec.gov, public domain, and every link opens the SEC’s copy. ChartRow does not summarise or interpret filings.
FAQ#
- Where can I read GMED's latest 10-K?
- GMED's latest annual report, a 10-K, was filed on Feb 24, 2026 for the fiscal year ended Dec 31, 2025. It is linked above and opens on EDGAR, the SEC's own site, where every exhibit is also listed.
- When did GMED last file an 8-K?
- On Aug 6, 2026: results of operations. An 8-K reports a material event between quarterly reports; the one that furnishes the quarter's results is filed under Item 2.02, last on Aug 6, 2026.
- Are GMED insiders buying or selling?
- Over the last 13 months insiders sold $9.8M in 7 sales and bought nothing on the open market; 30 other transactions (awards, exercises, tax withholding, gifts and plan purchases). The most recent sale: TOBIN JAMES R (Director) sold 30,000 shares on Sep 15, 2026 for $2.2M. Every figure is as the insider filed it on Form 4; a sale under a 10b5-1 plan was scheduled in advance.
- How many SEC filings has GMED made?
- 772 filings are on EDGAR under the registrant records that have been Globus Medical Inc., going back to 2003; 407 of them are insider ownership forms (Forms 3, 4, 5 and 144).